As Chief Medical Officer of Pfizer, Dr. Habtezion led Pfizer's Worldwide Medical & Safety organization responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications and vaccines. She led Pfizer’s Institute of Translational Equitable Medicine (ITEM), an initiative spanning key research, development, and medical activities to close gaps in health disparity by leveraging science, data, and translational expertise to integrate equity across Pfizer’s end-to-end pipeline. Prior to Pfizer, she was a practicing physician, scientist, tenured and endowed Stanford Professor of Medicine, where she led a large translational research lab focused on understanding immune mechanisms in gastrointestinal diseases. She authored over a hundred high impact publications in top peer-reviewed journals and served in multiple national and international scientific study sections, editorial boards. She is an Allen Distinguished Investigator, Past American Pancreatic Association President, an elected member of the American Society for Clinical Investigation and the Association of American Physicians.